Download PDF
Semin Thromb Hemost 2003; 29(2): 155-164
DOI: 10.1055/s-2003-38830
Copyright © 2003 by Thieme Medical Publishers, Inc., 333 Seventh Avenue, New York, NY 10001, USA. Tel.: +1(212) 584-4662

Prevention and Treatment of Arterial Thrombosis in Pregnancy

Peter Clark1 , Ian A. Greer2
  • 1Consultant Hematologist, Department of Transfusion Medicine, Ninewells Hospital and Medical School, Dundee, UK
  • 2University Department Obstetrics & Gynaecology, Royal Infirmary, Glasgow, UK
Further Information

Publication History

Publication Date:
23 April 2003 (online)

    Permissions and Reprints

ABSTRACT

In the last few years there has been a marked increase in the recognition of patients who are potentially at risk of arterial occlusive events during pregnancy. This includes patients with a previous history of arterial occlusion such as myocardial infarction and stroke, patients known to carry acquired or inherited thrombotic risk factors including sickle cell and myeloproliferative disorders, and patients with prosthetic heart valves. This review details the management options for prevention of arterial occlusions in these at-risk patients and outlines potential management strategies for arterial occlusions occurring during pregnancy.

KEYWORDS

Arterial thrombosis - pregnancy - thrombotic risk factors - prosthetic heart valves - sickle cell disease - management

REFERENCES

  • 1 Poort S, Rosendaal F, Reitsma P, Bertina K. A common genetic variation in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of venous thrombosis.  Blood . 1996;  88 3698-3703
    CrossrefPubMedGoogle Scholar
  • 2 Kang S, Wong P, Susmano A. et al . Thermolabile methylenetetrahydrofolate reductase: an inherited risk factor for coronary artery disease.  Hum Genet . 1991;  48 536-539
    PubMedGoogle Scholar
  • 3 Nelen W, Steegers E, Eskes T, Blom H. Genetic risk factors for unexplained early pregnancy loss.  Lancet . 1997;  350 861
    PubMedGoogle Scholar
  • 4 Rosendaal F, Siscovick D, Schwartz S. et al . A common prothrombin variant (20210 G to A) increases the risk of myocardial infarction in young women.  Blood . 1997;  90 1747-1750
    PubMedGoogle Scholar
  • 5 Folsom A, Rosamond W, Shahar E. et al . Prospective study of markers of haemostatic function with risk of ischemic stroke.  Circulation . 1999;  100 736-742
    CrossrefPubMedGoogle Scholar
  • 6 Rosendaal F. High levels of factor VIII and venous thrombosis.  Thromb Haemost . 2000;  83 1-2
    PubMedGoogle Scholar
  • 7 Wouters M, Boers G, Blom H. et al . Hyperhomocysteinemia: a risk factor in women with unexplained recurrent early pregnancy loss.  Fertil Steril . 1993;  60 820-825
    PubMedGoogle Scholar
  • 8 Chan W, Anand S, Ginsberg J. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature.  Arch Intern Med . 2000;  160 191-196
    CrossrefPubMedGoogle Scholar
  • 9 Gohlke-Barwolf C, Acar J, Burckhardt D. et al . Guidelines for the prevention of thromboembolic events in valvular heart disease.  J Heart Valve Dis . 1993;  2 398-410
    PubMedGoogle Scholar
  • 10 Bortolloti U, Milano A, Mazzucco A. Pregnancy in patients with a porcine valve prosthesis.  Am J Cardiol . 1982;  50 1051-1054
    CrossrefPubMedGoogle Scholar
  • 11 Nunez L, Larrea J, Gil Aguado M. et al . Pregnancy in 20 patients with bioprosthetic valve replacement.  Chest . 1983;  84 26-28
    PubMedGoogle Scholar
  • 12 Badduke B, Jamieson W, Miyagashima R. et al . Pregnancy and childbearing in a population with biologic heart protheses.  J Thorac Cardiovasc Surg . 1991;  102 179-186
    PubMedGoogle Scholar
  • 13 Jamieson W, Miller D, Akins C. et al . Pregnancy and bioprostheses: influence on structural valve deterioration.  Ann Thorac Surg . 1995;  60 S282-S287
    CrossrefPubMedGoogle Scholar
  • 14 Sbarouni E, Oakley C. Outcome of pregnancy in women with valve prothesis.  Br Heart J . 1994;  71 196-201
    CrossrefPubMedGoogle Scholar
  • 15 North R, Sadler L, Stewart A. et al . Long-term survival and valve-related complications in young women with cardiac valve replacements.  Circulation . 1999;  99 2669-2676
    CrossrefPubMedGoogle Scholar
  • 16 L'E Orme M, Lewis P, de Swiet M. et al . May mothers given warfarin breast feed their infants.  Br Med J . 1977;  1 1564-1565
    PubMedGoogle Scholar
  • 17 McKenna R, Cole E, Vasan U. Is warfarin sodium contraindicated in the lactating mother?.  J Pediat . 1983;  103 325-327
    CrossrefPubMedGoogle Scholar
  • 18 Ginsberg J. Fetal abnormalities and anticoagulants. In: Greer IA, Turpie AGG, Forbes CD, eds. Haemostasis and Thrombosis in Obstetrics and Gynaecology London: Chapman & Hall 1992: 361-369
    Google Scholar
  • 19 Hall J, Pauli R, Wilson K. Maternal and fetal sequelae of anticoagulation during pregnancy.  Am J Med . 1980;  68 122-140
    CrossrefPubMedGoogle Scholar
  • 20 Shaul W, Hall J. Multiple congenital anomalies associated with oral anticoagulants.  Am J Obstet Gynecol . 1977;  127 191-198
    PubMedGoogle Scholar
  • 21 Ginsberg J, Greer I, Hirsh J. Use of antithrombotic agents during pregnancy.  Chest . 2001;  119 122S-131S
    CrossrefPubMedGoogle Scholar
  • 22 Greer I. Haemostasis and thrombosis in pregnancy. In: Forbes C, Thomas D, Tuddenham E, eds. Haemostasis and Thrombosis Edinburgh: Churchill Livingstone 1994: 987-1015
    Google Scholar
  • 23 Flessa H, Kapstrom A, Glueck H, Will J. Placental transport of heparin.  Am J Obstet Gynecol . 1963;  28 469-472
    PubMedGoogle Scholar
  • 24 Ginsberg J, Hirsh J, Turner C. et al . Risks to the fetus of anticoagulation therapy during pregnancy.  Thromb Haemost . 1989;  61 197-203
    PubMedGoogle Scholar
  • 25 Ginsberg J, Kowalchuk G, Hirsh J. et al . Heparin therapy during pregnancy: risks to the fetus and mother.  Arch Intern Med . 1989;  149 2233-2236
    CrossrefPubMedGoogle Scholar
  • 26 Ginsberg J, Kowalchuk G, Hirsh J. et al . Heparin effect on bone density.  Thromb Haemost . 1990;  64 286-289
    PubMedGoogle Scholar
  • 27 Kelton J, Levine M. Heparin-induced thrombocytopaenia.  Semin Thromb Hemost . 1986;  12 59-62
    PubMedGoogle Scholar
  • 28 Warkentin T, Levine M, Hish J. et al . Heparin-induced thrombocytopaenia in patients treated with low molecular weight or unfractionated heparin.  N Engl J Med . 1995;  332 1330-1335
    CrossrefPubMedGoogle Scholar
  • 29 Dahlman T, Sjoberg H, Ringertz H. Bone mineral density during long-term prophylaxis with heparin in pregnancy.  Am J Obstet Gynecol . 1994;  170 1315-1320
    PubMedGoogle Scholar
  • 30 Barbour L, Kick S, Steiner J. et al . A prospective study of heparin-induced osteoporosis in pregnancy using bone densitometry.  Am J Obstet Gynecol . 1994;  170 862-869
    PubMedGoogle Scholar
  • 31 Dahlman T. Osteoporotic fractures and the recurrence of thromboembolism during pregnancy and the puerperium in 184 women undergoing thromboprophylaxis with heparin.  Am J Obstet Gynecol . 1993;  168 1265-1270
    CrossrefPubMedGoogle Scholar
  • 32 Monreal M, Lafoz E, Olive A, del Rio L, Bedia C. Comparison of subcutaneous unfractionated heparin (Fragmin) in patients with venous thromboembolism and contraindication to coumarin.  Thromb Haemost . 1994;  71 7-11
    PubMedGoogle Scholar
  • 33 Shaughnessy S, Hirsh J, Bhandari M. et al . Histomorphometric evaluation of heparin-induced bone loss after discontinuation of heparin treatment in rats.  Blood . 1999;  93 1231-1236
    PubMedGoogle Scholar
  • 34 Muir J, Andrew M, Hirsh J. et al . Histomorphometric analysis of the effects of standard heparin on trabecular bone in vivo.  Blood . 1996;  88 1314-1320
    PubMedGoogle Scholar
  • 35 Melissari E, Parker C, Wilson N. et al . Use of low molecular weight heparin in pregnancy.  Thromb Haemost . 1992;  68 652-656
    PubMedGoogle Scholar
  • 36 Shefras J, Farquharson R. Bone density studies in pregnant women receiving heparin.  Eur J Obstet Gynecol Reprod Biol . 1996;  65 171-174
    CrossrefPubMedGoogle Scholar
  • 37 Muir J, Hirsh J, Wietz J. et al . A histomorphometric comparison of the effects of heparin and low molecular weight heparin on cancellous bone in rats.  Blood . 1997;  89 3236-3242
    PubMedGoogle Scholar
  • 38 The Collaborative Low Dose Aspirin Study Group. CLASP: A randomized trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women.  Lancet . 1994;  343 619-629
    CrossrefPubMedGoogle Scholar
  • 39 Salazar E, Zajarias A, Gutierrez N, Iturbe I. The problem of cardiac valve prostheses, anticoagulants, and pregnancy.  Circulation . 1984;  70 169-177
    PubMedGoogle Scholar
  • 40 Ibarra-Perez C, Arevalo-Toledo N, Alvarez-de la Cadena O, Noriega-Guerra L. The course of pregnancy in patients with artificial heart valves.  Am J Med . 1976;  61 504-512
    CrossrefPubMedGoogle Scholar
  • 41 Lutz D, Noller K, Spittell J, Danielson G, Fish C. Pregnancy and its complications following cardiac valve prostheses.  Am J Obstet Gynecol . 1978;  131 460-468
    PubMedGoogle Scholar
  • 42 Chen W, Chan C, Lee P, Wang R, Wong V. Pregnancy in patients with prosthetic heart valves: an experience with 45 pregnancies.  Q J Med . 1982;  51 358-365
    PubMedGoogle Scholar
  • 43 O'Neill H, Blake S, Sugrue D, Macdonald D. Problems in the management of patients with artificial valves during pregnancy.  Br J Obstet Gynaecol . 1982;  89 940-943
    PubMedGoogle Scholar
  • 44 Sheikhzadeh A, Ghabusi P, Hakim S. et al . Congestive heart failure in valvular heart disease in pregnancies with and without valvular prostheses and anticoagulant therapy.  Clin Cardiol . 1983;  6 465-470
    PubMedGoogle Scholar
  • 45 Vitali E, Donatelli F, Quaini E, Groppelli G, Pellegrini A. Pregnancy in patients with mechanical prosthetic heart valves. Our experience regarding 98 pregnancies in 57 patients.  J Cardiovasc Surg . 1986;  27 221-227
    PubMedGoogle Scholar
  • 46 Ben Ismail M, Abid F, Trabelsi S, Taktak M, Fekih M. Cardiac valve prostheses, anticoagulation, and pregnancy.  Br Heart J . 1986;  55 101-105
    PubMedGoogle Scholar
  • 47 Lee P, Wang R, Chow J. et al . Combined use of warfarin and adjusted subcutaneous heparin during pregnancy in patients with an artificial heart valve.  J Am Coll Cardiol . 1986;  8 221-224
    PubMedGoogle Scholar
  • 48 Born D, Martinez E, Almeida P. et al . Pregnancy in patients with prosthetic heart valves: the effects of anticoagulation on mother, fetus, and neonate.  Am Heart J . 1992;  124 413-417
    CrossrefPubMedGoogle Scholar
  • 49 Gallus A S. Anticoagulants in the prevention and treatment of thromboembolic problems in pregnancy, including cardiac problems. In: Greer IA, Turpie AGG, Forbes CD, eds. Haemostasis and Thrombosis in Obstetrics and Gynaecology London: Chapman & Hall 1992: 319-347
    Google Scholar
  • 50 Caruso A, de Carolis S, Ferrazzani S. et al . Pregnancy outcome in women with cardiac valve prosthesis.  Eur J Obstet Gynecol Reprod Biol . 1994;  54 7-11
    CrossrefPubMedGoogle Scholar
  • 51 Clark P, Brennand J, Conkie J A. et al . Activated protein C sensitivity, protein C, protein S and coagulation in normal pregnancy.  Thromb Haemost . 1998;  79 1166-1170
    PubMedGoogle Scholar
  • 52 Gibson J, Ekevall K, Walker I D, Greer I. Puerperal thromboprophylaxis: comparison of the anti-Xa activity of enoxaparin and unfractionated heparin.  Br J Obstet Gynaecol . 1998;  105 795-796
    PubMedGoogle Scholar
  • 53 Nelson-Piercy C, Letsky E, de Swiet M. Low molecular weight heparin for obstetric thromboprophylaxis: experience of 69 pregnancies in 61 high risk women.  Am J Obstet Gynecol . 1996;  176 1062-1068
    PubMedGoogle Scholar
  • 54 Montalescot G, Polle V, Collet J. et al . Low molecular weight heparin after mechanical heart valve replacement.  Circulation . 2000;  101 1083-1086
    PubMedGoogle Scholar
  • 55 Lee L H, Liaw P C, Ng A S. Low molecular weight heparin for thromboprophylaxis during pregnancy in 2 patients with mechanical mitral valve replacement.  Thromb Haemost . 1996;  76 628-630
    PubMedGoogle Scholar
  • 56 Lev-Ran O, Kramer A, Gurevitch J, Shapira I, Mohr R. Low-molecular-weight heparin for prosthetic heart valves: treatment failure.  Ann Thorac Med . 2000;  69 264-266
    PubMedGoogle Scholar
  • 57 Ellison J, Thomson A J, Walker I D, Greer I A. Use of enoxaparin in a pregnant woman with a mechanical heart valve prosthesis.  Br J Obstet Gynaecol . 2001;  108 757-759
    CrossrefPubMedGoogle Scholar
  • 58 Roberts N, Ross D, Flint S, Arya R, Blott M. Thromboembolism in pregnant women with mechanical prosthetic heart valves anticoagulated with low molecular weight heparin.  Br J Obstet Gynaecol . 2001;  108 327-329
    CrossrefPubMedGoogle Scholar
  • 59 Rowan J A, McGowan L ME, Raudkivi P J, North R A. Enoxaparin treatment of women with mechanical valves during pregnancy.  Am J Obstet Gynecol . 2001;  185 633-637
    CrossrefPubMedGoogle Scholar
  • 60 Weatherall D. The hereditary anaemias.  Br Med J . 1997;  314 492-496
    PubMedGoogle Scholar
  • 61 Perry K, Morrison J. Disorders of hemoglobin structure, function and synthesis. In: Gleicher N, Gall S, Sibai B, Elkayam U, Galbraith R, Sarto G, eds. Principles and Practice of Medical Therapy in Pregnancy Norwalk, CT: Appleton & Lange 1992: 1007-1010
    Google Scholar
  • 62 Blake P, Martin J N, Perry K. Disseminated intravascular coagulation, autoimmune thrombocytopenic purpura and hemoglobinopathies. In: Knupel R, Drukker J, eds. High Risk Pregnancy A Team Approach. Philadelphia: WB Saunders 1993: 561-570
    Google Scholar
  • 63 Morrison J, Morrison F, Floyd R. et al . Use of continuous flow erythrocytopheresis in pregnant patients with sickle cell disease.  J Clin Apher . 1991;  6 224-226
    PubMedGoogle Scholar
  • 64 Howard R. Management of sickling conditions in pregnancy.  Br J Hosp Med . 1996;  56 7-10
    PubMedGoogle Scholar
  • 65 Howard R, Tuck S, Pearson T. Pregnancy in sickle cell disease in the UK: results of a multicentre survey of the effect of prophylactic blood transfusion on maternal and fetal outcome.  Br J Obstet Gynaecol . 1995;  102 947-951
    PubMedGoogle Scholar
  • 66 Ricks P. Exchange transfusion in sickle cell anaemia and pregnancy.  Obstet Gynecol . 1965;  25 117-121
    PubMedGoogle Scholar
  • 67 Cunningham F, Pritchard J, Mason R. Pregnancy and sickle cell hemoglobinopathies: results with and without prophylactic transfusion.  Obstet Gynecol . 1983;  62 419-423
    PubMedGoogle Scholar
  • 68 Koshy M, Burd L, Wallace D, Moawad A, Baron J. Prophylactic red cell transfusion in pregnant patients with sickle cell disease: a randomized cooperative study.  N Engl J Med . 1988;  319 1447-1452
    PubMedGoogle Scholar
  • 69 Bellucci S, Janvier M, Tobelem G. et al . Essential thrombocythemias. Clinical evolutionary and biological data.  Cancer . 1986;  58 2440-2447
    PubMedGoogle Scholar
  • 70 Barr I, Cohen P, Berken A, Lown B. Thrombocythemia and myocardial ischemia with normal coronary angiogram.  Arch Intern Med . 1974;  134 528-533
    CrossrefPubMedGoogle Scholar
  • 71 Okayasu N, Murata M, Ueda A. et al . Primary thrombocythemia and myocardial infarction in a 26-year-old woman with normal coronary arteriogram.  Jpn Heart J . 1981;  22 439-445
    PubMedGoogle Scholar
  • 72 Preston F, Martin J, Stewart R, Davies-Jones G. Thrombocytosis, circulating platelet aggregates, and neurological dysfunction.  Br Med J . 1979;  2 1561-1563
    PubMedGoogle Scholar
  • 73 Hussain S, Schwartz J, Friedman S, Chua S. Arterial thrombosis in essential thrombocythemia.  Am Heart J . 1978;  96 31-36
    CrossrefPubMedGoogle Scholar
  • 74 Eliyahu S, Shalev E. Essential thrombocythemia during pregnancy.  Obstet Gynecol Surv . 1997;  52 243-247
    CrossrefPubMedGoogle Scholar
  • 75 Hoagland H, Silverstein M. Primary thrombocythemia in the young patient.  Mayo Clin Proc . 1978;  53 578-580
    PubMedGoogle Scholar
  • 76 Waysbort A, Giroux M, Mansat V. et al . Experimental studies of transplacental passage of alpha interferon by two assay techniques.  Antimicrob Agents Chemother . 1993;  37 1323-1327
    PubMedGoogle Scholar
  • 77 Delage R, Demers C, Cantin G, Roy J. Treatment of essential thrombocythaemia during pregnancy with interferon-alpha.  Obstet Gynecol . 1996;  87 814-817
    PubMedGoogle Scholar
  • 78 Lorincz A, Moore R. Puerperal cerebral venous thrombosis.  Am J Obstet Gynecol . 1962;  83 311-318
    PubMedGoogle Scholar
  • 79 Goldman J, Eckerling B, Gans B. Intracranial venous sinus thrombosis in pregnancy and puerperium: report of 15 cases.  J Obstet Gynaecol Br Commun . 1964;  71 791-796
    PubMedGoogle Scholar
  • 80 Cross J, Castro P, Jennett W. Cerebral strokes associated with pregnancy and the puerperium.  Br Med J . 1968;  3 214-218
    PubMedGoogle Scholar
  • 81 Wiebers D, Whisnant J. The incidence of stroke among pregnant women in Rochester, Minnesota, 1955-1979.  JAMA . 1985;  254 3055-3057
    CrossrefPubMedGoogle Scholar
  • 82 Simolke G, Cox S, Cunningham F. Cerebrovascular accidents complicating pregnancy and the puerperium.  Obstet Gynecol . 1991;  78 37-42
    PubMedGoogle Scholar
  • 83 Cunningham F, Levenko K. Management of pregnancy-induced hypertension. In: Rubin P, ed. Handbook of Hypertension, vol. 10 Oxford: Elsevier 1988: 209-319
    Google Scholar
  • 84 Donaldson J. Neurological problems of pregnancy. In: Bradley W, Daroff R, Fenichel G, Marsden C, eds. Neurology in Clinical Practice Boston: Butterworth-Heinmann 1991: 809-815
    Google Scholar
  • 85 Sharshar T, Lamy C, Mas J. Incidence and causes of strokes associated with pregnancy and puerperium: A study in public hospitals of Ile de France.  Stroke . 1995;  26 930-936
    CrossrefPubMedGoogle Scholar
  • 86 Kittner S, Stern B, Feeser B. et al . Pregnancy and the risk of stroke.  N Engl J Med . 1996;  335 768-774
    CrossrefPubMedGoogle Scholar
  • 87 Lanska D, Kryscio R. Risk factors for peripartum and postpartum stroke and intracranial venous thrombosis.  Stroke . 2000;  31 1274-1282
    CrossrefPubMedGoogle Scholar
  • 88 Weir B, Macdonald N, Mielke B. Intracranial vascular complications of choriocarcinoma.  Neurosurgery . 1978;  2 138-142
    PubMedGoogle Scholar
  • 89 Branch D, Silver R, Blackwell J, Reading J, Scott J. Outcome of treated pregnancies in women with antiphospholipid syndrome: an update of the Utah experience.  Obstet Gynecol . 1992;  80 614-620
    PubMedGoogle Scholar
  • 90 Newman G, Mitchell J. Homocysteinuria presenting as multiple arterial occlusions.  Q Med J . 1984;  LIII 251-258
    PubMedGoogle Scholar
  • 91 Mas J, Lamy C. Stroke in pregnancy and the puerperium.  J Neurol . 1998;  245 305-313
    CrossrefPubMedGoogle Scholar
  • 92 Lamy C, Hamon J B, Coste J, Mas J L, for the French Study Group on Stroke in Pregnancy. Ischemic stroke in young women: risk of recurrence during subsequent pregnancies.  Neurology . 2000;  55 269-274
    PubMedGoogle Scholar
  • 93 Hankins G, Wendel G, Leveno K J, Stoneham J. Myocardial infarction during pregnancy.  Obstet Gynecol . 1985;  65 139-146
    PubMedGoogle Scholar
  • 94 Roth A, Elkayam U. Acute myocardial infarction associated with pregnancy.  Ann Intern Med . 1996;  125 751-762
    PubMedGoogle Scholar
  • 95 Yoshimura T, Ito M, Nakamura T, Okamura H. The influence of labor on thrombotic and fibrinolytic systems.  Eur J Obstet Gynecol Reprod Biol . 1992;  44 195-199
    CrossrefPubMedGoogle Scholar
  • 96 Menallo-Estrella P, Barker A. Histopathologic findings in human aortic media associated with pregnancy.  Arch Pathol Lab Med . 1967;  83 336-341
    PubMedGoogle Scholar
  • 97 Turrentine M, Braems G, Ramirez M. Use of thrombolytics for the treatment of thromboembolic disease during pregnancy.  Obstet Gynecol Surv . 1995;  50 534-541
    PubMedGoogle Scholar
  • 98 Hall R, Young C, Sutton G, Campbell S. Treatment of acute massive pulmonary embolism by streptokinase during labour and delivery.  Br Med J . 1972;  4 647-649
    PubMedGoogle Scholar
  • 99 Faghrer B, Ahlgren M, Astedt B. Acute massive pulmonary embolism treated with streptokinase during labor and the early puerperium.  Acta Obstet Gynecol Scand . 1990;  69 659-661
    PubMedGoogle Scholar
  • 100 Ludwig H, Genz H. Thrombolytic treatment during pregnancy.  Thromb Haemost . 1981;  46 438
    PubMedGoogle Scholar
  • 101 Ulm M, Obwegeser R, Ploeckinger B. et al . A case of myocardial infarction complicating pregnancy-a role for prostacyclin synthesis stimulating plasma factor and lipoprotein (a)?.  Thromb Res . 1996;  83 237-242
    CrossrefPubMedGoogle Scholar
  • 102 American Academy of Pediatrics Committee on Drugs. The transfer of drugs and other chemicals into human milk.  Pediatrics . 1994;  93 137-150
    PubMedGoogle Scholar
  • 103 Shotan A, Widerhorn J, Hurst A, Elkayam U. Risk of angiotensin-converting enzyme inhibition during pregnancy: experimental and clinical evidence, potential mechanisms, and recommendations for use.  Am J Med . 1994;  96 451-456
    CrossrefPubMedGoogle Scholar
  • 104 Cohen W, Steinman T, Patsner B. et al . Acute myocardial infarction in a pregnant woman at term.  JAMA . 1983;  250 2179-2181
    CrossrefPubMedGoogle Scholar